EUVIMEDOdkrijte EUVIMED
CrossrefInformacijska kartica

Rimonabant in the management of cardiovascular risk

Anthony Barnett

Future Prescriber · 2006

DOI: 10.1002/fps.13 ↗
PovzetekBibliografski podatki

Povzetek

Abstract The current obesity pandemic is recognised as a major factor contributing to the global burden of disease. Indeed, the rising tide of obesity in the USA and Europe has been shown to contribute directly to high levels of type 2 diabetes, cardiovascular disease and certain cancers. Increases in body weight leading to central obesity are associated with pathological changes in blood lipid profiles, predisposing subjects to atherosclerosis, and with metabolic changes in glycaemic control that contribute to cardiovascular damage. Copyright © 2006 John Wiley & Sons, Ltd.

Znanje, ki ustreza vašemu delu.

Od brezplačnega začetka in osebnega iskanja literature do celotnega paketa Research Suite.

Ogled tarif →

Ali so vključena vsa polna besedila založnikov?

Ne. Bibliografski zapisi, povzetki in celotna besedila so različne vsebine. Ali je celotno besedilo na voljo, je odvisno od vira, odprtega dostopa in vaših obstoječih licenc. Paket EUVIMED ne nadomešča dodatnih pravic založnikov.

Ogled tarif →